Bluefin Capital Management’s STAAR Surgical STAA Stock Holding History

Bluefin Capital Management’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$231K	–	217
2025 Q4	$231K	Buy	+10,000	New	+$258K	0.06%	138

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bluefin Capital Management's STAA Position: Q1 2026 in Review

Bluefin Capital Management sold out of STAAR Surgical (STAA) in Q1 2026, closing a stake of 10,000 shares — an estimated $231K sold.

Bluefin Capital Management first reported a position in STAA in Q4 2025 and held it in 1 quarter. The position peaked at $231K in Q4 2025. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

Bluefin Capital Management reported no remaining STAAR Surgical position as of Q1 2026 after selling out during the quarter.
Bluefin Capital Management sold 10,000 STAAR Surgical shares in Q1 2026, an estimated $231K.
Bluefin Capital Management first reported a position in STAAR Surgical in Q4 2025 and held it in 1 quarter.
Bluefin Capital Management's STAAR Surgical position peaked at $231K in Q4 2025.
187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Bluefin Capital Management's 13F filing for Q1 2026, filed 15 May 2026.